CrushSCI.com
Journal Selection & Manuscript Polishing Services
CANCER TREATMENT REVIEWS journal cover Medicine
Back to journal directory

Review Cycle Records

CANCER TREATMENT REVIEWS

Elsevier SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
47.6Average days
48.5Median days
27Fastest days
66Longest days
1302025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

27 days

The role of the 21-gene assay in the neoadjuvant setting for hormone receptor-positive HER2-negative breast cancer: Impact on systemic and surgical treatment decisions

AuthorsÁ.Guerrero Zotano; T.M. Allweis; R. Foerster; C. Palmieri; O. Gluz; S. Chia; C. Sotiriou; G. Bianchini

AffiliationsMedical Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Dept. of Breast Surgery, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University, Jerusalem, Israel; Exact Sciences (Abbott Cancer Diagnostics), Baar, Zug, Switzerland; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; University of Liverpool, Liverpool, UK; West German Study Group (WSG), Moenchengladbach, Germany; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach, Germany; University Clinics Cologne, Women’s Clinic and Breast Center, Cologne, Germany; Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada; Breast Cancer Translational Research Laboratory, Department of Medical Oncology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium; Université Libre de Bruxelles (ULB), Brussels, Belgium; Medical Oncology Department, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy

Source PDF DOI Publisher page
62 days

Prognostic role of postoperative circulating tumor DNA in metastatic colorectal cancer treated with curative intent: A systematic review and meta-analysis

AuthorsClaudia Cardone; Sergio Facchini; Bruna de Oliveira Ascef; Antonino Cassata; Alfonso De Stefano; Paolo Chiodini; Antonio Avallone

AffiliationsExperimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori- IRCCS-Fondazione G. Pascale, Naples, Italy; Department of Mental and Physical Health and Preventive Medicine. Medical Statistics Unit. Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy

Source PDF DOI Publisher page
64 days

Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal

AuthorsAldo Caltavituro; Roberto Buonaiuto; Alessandra Longobardi; Paola Trasacco; Claudia Martinelli; Giuseppe Di Grazia; Roberto Pacelli; Grazia Arpino; Carmine De Angelis; Roberta Caputo; Michelino De Laurentiis; Elena Laakmann; Leonor Vasconcelos de Matos; Mário Fontes-Sousa; Mette van Ramshorst; Volkmar Mueller; Elisa Agostinetto; Sabine Linn; Michelangelo De Angelis; Francesco Schettini; Mario Giuliano

AffiliationsOncology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Napoli, Italy; Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy; University Medical Center Hamburg-Eppendorf, Department of Gynecology, Hamburg, Germany; Breast Cancer Unit, Champalimaud Clinical Centre, Champalimaud Foundation, Lisbon, Portugal; Oncology Unit, Hospital CUF Tejo, Lisbon, Portugal, Oncology Unit, Unidade Local de Saúde Lisboa Ocidental, Lisbon, Portugal; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Gynecology, University Medical Center Hamburg 20246 Hamburg, Germany; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands; IRCCS Istituto Neurologico Mediterraneo Neuromed, Division of Neurosurgery, Isernia, Italy; Clinic Barcelona Comprehensive Cancer Center, Hospital Clinic of Barcelona, Barcelona, Spain; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain

Source PDF DOI Publisher page
37 days

KRAS G12C-mutant non-small cell lung cancer: A practical guide for clinicians

AuthorsJordi Remon; Giulia La-Cava; Maxime Borgeaud; Stephanie P.L. Saw; Lizza EL Hendriks; Biagio Ricciuti

AffiliationsDepartment of Medical Oncology, Thoracic Group, Gustave Roussy, Villejuif, France; Paris-Saclay University, Paris, France; Department of Medicine and Surgery, University Campus Bio-Medico of Rome, Rome, Italy; Oncology Department, University Hospital Geneva, Geneva, Switzerland; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Department of Pulmonary Diseases, Maastricht University Medical Centre (+), GROW Research Institute for Oncology and Reproduction, Maastricht, the Netherlands; Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States

Source PDF DOI Publisher page
32 days

Circulating tumor DNA for predicting recurrence and mortality in patients with resected Melanoma: A systematic review and meta-analysis

AuthorsPedro C. Abrahão Reis; Mariana Macambira Noronha; João Pedro Oliveira; João Evangelista Ponte Conrado; Isabella Romagnoli Buonopane; Carlos Diego Holanda Lopes; Daniel V. Araujo; Erick F. Saldanha

AffiliationsUniversidade Federal do Rio de Janeiro (UFRJ), RJ, Brazil; Universidade Federal do Ceará (UFC), CE, Brazil; Universidade Federal da Bahia (UFBA), BA, Brazil; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, ON, Canada; Department of Medicine, University of Toronto, ON, Canada; University of Florida, Gainesville, FL, USA; Harvard T. H. Chan School of Public Health, Harvard University, MA, USA

Source PDF DOI Publisher page
57 days

Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors

AuthorsIrene Hernández de Córdoba Sánchez; Mercedes Avedillo Ruidiaz; Victor Moreno; Henry Long; Paloma Cejas

AffiliationsDepartment of Medical Oncology, University Hospital Infanta Sofía, San Sebastián de los Reyes, 28702 Madrid, Spain; Department of Medical Oncology, University Hospital Fundación Jiménez Díaz, Moncloa-Aravaca, 28040 Madrid, Spain; START Madrid-FJD Early Phase Clinical Trials Unit, University Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA

Source PDF DOI Publisher page
30 days

Progress toward personalized management of stage II/III triple negative breast cancer

AuthorsIrene Valle; Joana M Ribeiro; Thomas Grinda; Marleen Kok; Barbara Pistilli; Gustavo Werutsky; Elie Rassy

AffiliationsDepartment of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France; Oncology Unit, AOUC - Careggi University Hospital, University of Florence, Florence, Italy; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; INSERM 1279, Gustave Roussy, Villejuif, France; Hospital São Lucas PUCRS, Porto Alegre, Brazil

Source PDF DOI Publisher page
66 days

Management of infections in the outpatient care of patients with cancer

AuthorsMichael Sandherr; Georg Maschmeyer; Christina Rieger

AffiliationsGerman Society of Hematology and Medical Oncology, Bauhofstr. 12, 10117 Berlin, Germany; German Society of Hematology and Medical Oncology and Charité University, Medicine Bauhofstr. 12, 10117 Berlin, Germany; Hematology Oncology Germering, Landsberger Str.27, 82110 Germering, Germany

Source PDF DOI Publisher page
40 days

Expanding the therapeutic Frontier: Liver transplantation for unresectable colorectal liver metastases

AuthorsAlex B. Munster; Umair Mahmood; Heather Fuller; Hajun Seo; Jamie Murphy; Krishna Menon; Charles Imber; Chetan Bhan; Khurum Khan

AffiliationsDepartment of Cancer Services, Whittington Health NHS Trust, London, UK; Department of Gastrointestinal Oncology, University College London Hospitals NHS Foundation Trust, London, UK; University College London Medical School, London, UK; Cleveland Clinic London, London, UK; Department of General Surgery, University College London Hospitals NHS Foundation Trust, London, UK; Department of Oncology, University College London Cancer Institute, London, UK; The London Clinic in collaboration with Northwestern Medicine, UK

Source PDF DOI Publisher page
61 days

Neoantigen-based dendritic cell vaccines in lung cancer: overcoming immunosuppressive barriers for durable antitumor immunity

AuthorsZhang Li; Zhang Feiyue; Huang Luyu; Zhang Wenqiang; Mahmoud Ismail; Jens-C Rueckert

AffiliationsDepartment of Surgery, Competence Center of Thoracic Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Department of Thoracic Surgery, Klinikum Ernst von Bergmann Potsdam, Academic Hospital of the Charité-Universitätsmedizin Humboldt University Berlin, Potsdam, Germany; Department of Oncology, the Sixth Affiliated Hospital of Kunming Medical University, Yuxi, China

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.